Epiretinal Membrane Surgery for a Patient with Dyskinesia Related to Parkinson’s Disease Using Intravenous Dexmedetomidine Administration
General anesthesia is usually selected when patients cannot remain still during surgery with local anesthesia. However, damage to the lungs from positive pressure ventilation under general anesthesia is a major concern in patients with Parkinson’s disease. We report a case in which dyskinesia relate...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2022-11-01
|
Series: | Case Reports in Ophthalmology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/527157 |
_version_ | 1811290867476987904 |
---|---|
author | Takafumi Suzuki Hirofumi Sasajima Yoshiki Ueta Hidetoshi Ishida Yoshihiro Hashimoto Naoko Tachi |
author_facet | Takafumi Suzuki Hirofumi Sasajima Yoshiki Ueta Hidetoshi Ishida Yoshihiro Hashimoto Naoko Tachi |
author_sort | Takafumi Suzuki |
collection | DOAJ |
description | General anesthesia is usually selected when patients cannot remain still during surgery with local anesthesia. However, damage to the lungs from positive pressure ventilation under general anesthesia is a major concern in patients with Parkinson’s disease. We report a case in which dyskinesia related to Parkinson’s disease was attenuated by intravenous dexmedetomidine (DEX) administration, following which epiretinal membrane (ERM) and inner limited membrane peeling could be smoothly performed. A 68-year-old woman with systemic dyskinesia related to Parkinson’s disease underwent cataract surgery for her right eye with local anesthesia (topical anesthesia with 4% lidocaine and sub-Tenon’s anesthesia with 2% lidocaine and 30% nitrous oxide inhalation). During the surgery, continuous involuntary facial movement related to Parkinson’s disease remained uncontrollable. One week later, she underwent cataract surgery and pars plana vitrectomy for the ERM of her left eye. In addition to local anesthesia (topical anesthesia with 4% lidocaine and retrobulbar anesthesia with 2% lidocaine and 30% nitrous oxide inhalation), the patient received intravenous DEX, which halted movement from the beginning of surgery until the end. Therefore, ERM surgery was performed without the influence of dyskinesia. This case highlights that intravenous DEX administration can inhibit dyskinesia related to Parkinson’s disease during ERM surgery, which is among the most delicate microscopic procedures performed in ophthalmological settings. Additional studies are required to examine the actual effectiveness of DEX administration in patients with Parkinson’s disease-related dyskinesia undergoing ophthalmological procedures. |
first_indexed | 2024-04-13T04:20:47Z |
format | Article |
id | doaj.art-eab504c8617345709fc1d70ec77106ed |
institution | Directory Open Access Journal |
issn | 1663-2699 |
language | English |
last_indexed | 2024-04-13T04:20:47Z |
publishDate | 2022-11-01 |
publisher | Karger Publishers |
record_format | Article |
series | Case Reports in Ophthalmology |
spelling | doaj.art-eab504c8617345709fc1d70ec77106ed2022-12-22T03:02:48ZengKarger PublishersCase Reports in Ophthalmology1663-26992022-11-0113396797110.1159/000527157527157Epiretinal Membrane Surgery for a Patient with Dyskinesia Related to Parkinson’s Disease Using Intravenous Dexmedetomidine AdministrationTakafumi Suzuki0https://orcid.org/0000-0002-7385-415XHirofumi Sasajima1https://orcid.org/0000-0002-2256-8217Yoshiki Ueta2https://orcid.org/0000-0002-0115-3311Hidetoshi Ishida3Yoshihiro Hashimoto4Naoko Tachi5https://orcid.org/0000-0003-3750-7617Department of Ophthalmology, Shinseikai Toyama Hospital, Toyama, JapanDepartment of Ophthalmology, Shinseikai Toyama Hospital, Toyama, JapanDepartment of Ophthalmology, Shinseikai Toyama Hospital, Toyama, JapanDepartment of Ophthalmology, Shinseikai Toyama Hospital, Toyama, JapanDepartment of Ophthalmology, Shinseikai Toyama Hospital, Toyama, JapanDepartment of Ophthalmology, Shinseikai Toyama Hospital, Toyama, JapanGeneral anesthesia is usually selected when patients cannot remain still during surgery with local anesthesia. However, damage to the lungs from positive pressure ventilation under general anesthesia is a major concern in patients with Parkinson’s disease. We report a case in which dyskinesia related to Parkinson’s disease was attenuated by intravenous dexmedetomidine (DEX) administration, following which epiretinal membrane (ERM) and inner limited membrane peeling could be smoothly performed. A 68-year-old woman with systemic dyskinesia related to Parkinson’s disease underwent cataract surgery for her right eye with local anesthesia (topical anesthesia with 4% lidocaine and sub-Tenon’s anesthesia with 2% lidocaine and 30% nitrous oxide inhalation). During the surgery, continuous involuntary facial movement related to Parkinson’s disease remained uncontrollable. One week later, she underwent cataract surgery and pars plana vitrectomy for the ERM of her left eye. In addition to local anesthesia (topical anesthesia with 4% lidocaine and retrobulbar anesthesia with 2% lidocaine and 30% nitrous oxide inhalation), the patient received intravenous DEX, which halted movement from the beginning of surgery until the end. Therefore, ERM surgery was performed without the influence of dyskinesia. This case highlights that intravenous DEX administration can inhibit dyskinesia related to Parkinson’s disease during ERM surgery, which is among the most delicate microscopic procedures performed in ophthalmological settings. Additional studies are required to examine the actual effectiveness of DEX administration in patients with Parkinson’s disease-related dyskinesia undergoing ophthalmological procedures.https://www.karger.com/Article/FullText/527157dexmedetomidineparkinson’s diseasedyskinesiaepiretinal membranepars plana vitrectomy |
spellingShingle | Takafumi Suzuki Hirofumi Sasajima Yoshiki Ueta Hidetoshi Ishida Yoshihiro Hashimoto Naoko Tachi Epiretinal Membrane Surgery for a Patient with Dyskinesia Related to Parkinson’s Disease Using Intravenous Dexmedetomidine Administration Case Reports in Ophthalmology dexmedetomidine parkinson’s disease dyskinesia epiretinal membrane pars plana vitrectomy |
title | Epiretinal Membrane Surgery for a Patient with Dyskinesia Related to Parkinson’s Disease Using Intravenous Dexmedetomidine Administration |
title_full | Epiretinal Membrane Surgery for a Patient with Dyskinesia Related to Parkinson’s Disease Using Intravenous Dexmedetomidine Administration |
title_fullStr | Epiretinal Membrane Surgery for a Patient with Dyskinesia Related to Parkinson’s Disease Using Intravenous Dexmedetomidine Administration |
title_full_unstemmed | Epiretinal Membrane Surgery for a Patient with Dyskinesia Related to Parkinson’s Disease Using Intravenous Dexmedetomidine Administration |
title_short | Epiretinal Membrane Surgery for a Patient with Dyskinesia Related to Parkinson’s Disease Using Intravenous Dexmedetomidine Administration |
title_sort | epiretinal membrane surgery for a patient with dyskinesia related to parkinson s disease using intravenous dexmedetomidine administration |
topic | dexmedetomidine parkinson’s disease dyskinesia epiretinal membrane pars plana vitrectomy |
url | https://www.karger.com/Article/FullText/527157 |
work_keys_str_mv | AT takafumisuzuki epiretinalmembranesurgeryforapatientwithdyskinesiarelatedtoparkinsonsdiseaseusingintravenousdexmedetomidineadministration AT hirofumisasajima epiretinalmembranesurgeryforapatientwithdyskinesiarelatedtoparkinsonsdiseaseusingintravenousdexmedetomidineadministration AT yoshikiueta epiretinalmembranesurgeryforapatientwithdyskinesiarelatedtoparkinsonsdiseaseusingintravenousdexmedetomidineadministration AT hidetoshiishida epiretinalmembranesurgeryforapatientwithdyskinesiarelatedtoparkinsonsdiseaseusingintravenousdexmedetomidineadministration AT yoshihirohashimoto epiretinalmembranesurgeryforapatientwithdyskinesiarelatedtoparkinsonsdiseaseusingintravenousdexmedetomidineadministration AT naokotachi epiretinalmembranesurgeryforapatientwithdyskinesiarelatedtoparkinsonsdiseaseusingintravenousdexmedetomidineadministration |